Eriksson E, Tengborn L, Risberg B
Department of Surgery I, Ostra Hospital, University of Göteborg, Sweden.
Thromb Haemost. 1989 Jun 30;61(3):511-6.
Blood collected in different anticoagulant/antiplatelet agents (ETP, EDTA, citrate, citrate/citric acid pH 4.5 and CTAD) was compared with respect to determination of PAI-1 activity and PAI-1 antigen. beta TG and PF4 were analysed as markers of platelet release. Both the middle layer and the remaining layer of the plasma were studied. Moreover vWF:Ag, FVII:Ag, ECLT, t-PA:Ag, t-PA activity, APTT, VIII:C and VII:C were assayed in blood collected in citrate and CTAD. PAI-1 activity showed the same level in all citrate based anticoagulants and ETP and no increase was found in blood standing for 2 hours at room temperature. On the contrary quick handling was most important for determination of PAI-1 antigen. In tubes anticoagulated with citrate no significant increase was found if the sample was prepared within 1 hour. EDTA was not suitable as anticoagulant mixture. Tubes containing the antiplatelet mixture CTAD could be used for determination of PAI activity, PAI antigen, vWF:Ag, FVII:Ag, t-PA activity and APTT. For measurement of PAI-1 antigen quick handling of blood anticoagulated with antiplatelet mixtures are preferable, and plasma treated in that manner could also be used to assay some hemostasis parameters.
对采集于不同抗凝/抗血小板制剂(ETP、乙二胺四乙酸(EDTA)、柠檬酸盐、pH 4.5的柠檬酸盐/柠檬酸和CTAD)中的血液,就纤溶酶原激活物抑制剂-1(PAI-1)活性和PAI-1抗原的测定进行了比较。对β-血小板球蛋白(βTG)和血小板第4因子(PF4)作为血小板释放标志物进行了分析。对血浆的中间层和剩余层均进行了研究。此外,对采集于柠檬酸盐和CTAD中的血液测定了血管性血友病因子抗原(vWF:Ag)、凝血因子VII抗原(FVII:Ag)、内皮细胞层促凝活性(ECLT)、组织型纤溶酶原激活物抗原(t-PA:Ag)、t-PA活性、活化部分凝血活酶时间(APTT)、因子VIII促凝活性(VIII:C)和因子VII促凝活性(VII:C)。PAI-1活性在所有基于柠檬酸盐的抗凝剂和ETP中显示相同水平,且在室温下静置2小时的血液中未发现升高。相反,快速处理对于PAI-1抗原的测定最为重要。在用柠檬酸盐抗凝的试管中,如果在1小时内制备样品则未发现显著升高。EDTA不适合作为抗凝混合物。含有抗血小板混合物CTAD的试管可用于PAI活性、PAI抗原、vWF:Ag、FVII:Ag、t-PA活性和APTT的测定。对于PAI-1抗原的测定,用抗血小板混合物抗凝的血液进行快速处理更佳,以这种方式处理的血浆也可用于检测一些止血参数。